Eledon Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 25,774 | 0.0431% |
Hedge Funds | 6,293,282 | 10.5% |
VC/PE Firms | 7,127,982 | 11.9% |
Institutions | 12,237,878 | 20.5% |
General Public | 34,054,359 | 57% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 146.9%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
6,293,282 | US$26.7m | 0% | 0.73% | |||
3,566,338 | US$15.2m | 0% | 0.17% | |||
3,561,644 | US$15.1m | 0% | 0.57% | |||
2,364,000 | US$10.0m | 1.2% | 0.24% | |||
1,565,487 | US$6.7m | 41.8% | no data | |||
1,500,000 | US$6.4m | 0% | 0.05% | |||
1,434,727 | US$6.1m | -32% | 0.1% | |||
1,297,321 | US$5.5m | 0.02% | 0.9% | |||
842,892 | US$3.6m | 24.8% | 0.03% | |||
600,000 | US$2.5m | 0% | 0.17% | |||
500,000 | US$2.1m | 0% | 0.01% | |||
443,001 | US$1.9m | 0% | no data | |||
378,058 | US$1.6m | 9.74% | no data | |||
275,000 | US$1.2m | 71.9% | 0.86% | |||
215,868 | US$917.4k | 39.2% | no data | |||
161,492 | US$686.3k | 0% | no data | |||
135,873 | US$577.5k | -0.66% | no data | |||
91,893 | US$390.5k | 0% | no data | |||
83,471 | US$354.8k | 3,770% | no data | |||
58,041 | US$246.7k | 0% | 0.04% | |||
51,849 | US$220.4k | 0% | 0.01% | |||
45,000 | US$191.3k | 0% | 0.71% | |||
34,223 | US$145.5k | 13.2% | no data | |||
33,400 | US$142.0k | 0% | no data | |||
30,344 | US$129.0k | 0% | 0.01% |